![Todd Saunders](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Todd Saunders
President chez
Osteal Therapeutics, Inc.
Profil
Todd Saunders is currently the Vice President of Marketing at Osteal Therapeutics, Inc. since 2022.
He is also a Partner at Stanmore Medical Investments LLC since 2013.
Mr. Saunders has a graduate degree from Dartmouth College and undergraduate degrees from Dartmouth College and Bates College, with the latter being conferred in 2000.
Postes actifs de Todd Saunders
| Sociétés | Poste | Début |
|---|---|---|
Stanmore Medical Investments LLC
 Stanmore Medical Investments LLC Investment ManagersFinance Stanmore Medical Investments invests in companies located in the United States. The firm focuses on medical devices sector. It provides financing for early stage capital requirements with an investment size ranging from USD 1 - 3 million. | Private Equity Investor | 01/02/2013 |
Osteal Therapeutics, Inc.
 Osteal Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage pharmaceutical company developing novel musculoskeletal therapeutics to treat orthopedic infections | President | 01/06/2022 |
Formation de Todd Saunders
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
24
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Dartmouth College
 Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bates College
 Bates College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanmore Medical Investments LLC
Stanmore Medical Investments LLC Investment ManagersFinance Stanmore Medical Investments invests in companies located in the United States. The firm focuses on medical devices sector. It provides financing for early stage capital requirements with an investment size ranging from USD 1 - 3 million. | Finance |
Osteal Therapeutics, Inc.
Osteal Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage pharmaceutical company developing novel musculoskeletal therapeutics to treat orthopedic infections | Health Technology |
